186 related articles for article (PubMed ID: 15184544)
1. Protection in a mouse peritonitis model mediated by iron-regulated outer-membrane protein of Salmonella typhi coupled to its Vi antigen.
Chibber S; Bhardwaj SB
J Med Microbiol; 2004 Jul; 53(Pt 7):705-709. PubMed ID: 15184544
[TBL] [Abstract][Full Text] [Related]
2. Protection mediated by antibodies to iron-regulated outer-membrane proteins of S. typhi in a mouse peritonitis model.
Sood S; Rishi P; Dhawan V; Sharma S; Ganguly NK
Mol Cell Biochem; 2005 May; 273(1-2):69-78. PubMed ID: 16013441
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi.
Singh M; Ganguly NK; Kumar L; Vohra H
Microbiol Immunol; 1999; 43(6):535-42. PubMed ID: 10480549
[TBL] [Abstract][Full Text] [Related]
4. Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM
Micoli F; Bjarnarson SP; Arcuri M; Aradottir Pind AA; Magnusdottir GJ; Necchi F; Di Benedetto R; Carducci M; Schiavo F; Giannelli C; Pisoni I; Martin LB; Del Giudice G; MacLennan CA; Rappuoli R; Jonsdottir I; Saul A
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24443-24449. PubMed ID: 32900928
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of purified Vi polysaccharide typhoid vaccine.
Park JH; Hong JJ; Choi ES; Lee JW; Park JH
J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
[TBL] [Abstract][Full Text] [Related]
6. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.
Cryz SJ; Fürer E; Baron LS; Noon KF; Rubin FA; Kopecko DJ
Infect Immun; 1989 Dec; 57(12):3863-8. PubMed ID: 2807550
[TBL] [Abstract][Full Text] [Related]
8. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
9. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
Robbins JD; Robbins JB
J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
[TBL] [Abstract][Full Text] [Related]
10. S.Typhi derived OmpC peptide conjugated with Vi-polysaccharide evokes better immune response than free Vi-polysaccharide in mice.
Haque S; Sengupta S; Gupta D; Bhan MK; Kumar R; Khan A; Jailkhani B
Biologicals; 2019 Nov; 62():50-56. PubMed ID: 31606267
[TBL] [Abstract][Full Text] [Related]
11. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
Das S; Chowdhury R; Pal A; Okamoto K; Das S
Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
[TBL] [Abstract][Full Text] [Related]
12. The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen.
Marshall JL; Flores-Langarica A; Kingsley RA; Hitchcock JR; Ross EA; López-Macías C; Lakey J; Martin LB; Toellner KM; MacLennan CA; MacLennan IC; Henderson IR; Dougan G; Cunningham AF
J Immunol; 2012 Dec; 189(12):5527-32. PubMed ID: 23162127
[TBL] [Abstract][Full Text] [Related]
13. Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.
Micoli F; Rondini S; Pisoni I; Proietti D; Berti F; Costantino P; Rappuoli R; Szu S; Saul A; Martin LB
Vaccine; 2011 Jan; 29(4):712-20. PubMed ID: 21115057
[TBL] [Abstract][Full Text] [Related]
14. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
[TBL] [Abstract][Full Text] [Related]
15. Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.
Moreno-Eutimio MA; Tenorio-Calvo A; Pastelin-Palacios R; Perez-Shibayama C; Gil-Cruz C; López-Santiago R; Baeza I; Fernández-Mora M; Bonifaz L; Isibasi A; Calva E; López-Macías C
Immunology; 2013 Aug; 139(4):459-71. PubMed ID: 23432484
[TBL] [Abstract][Full Text] [Related]
16. A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.
Lu YJ; Zhang F; Sayeed S; Thompson CM; Szu S; Anderson PW; Malley R
Vaccine; 2012 May; 30(23):3405-12. PubMed ID: 22465750
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses.
Bhuiyan MS; Kalsy A; Arifuzzaman M; Charles RC; Harris JB; Calderwood SB; Qadri F; Ryan ET
Am J Trop Med Hyg; 2020 Sep; 103(3):1032-1038. PubMed ID: 32720632
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic potential of cytolethal distending toxin B (CdtB) subunit of typhoid toxin against Typhoid fever.
Thakur R; Pathania P; Kaur N; Joshi V; Kondepudi KK; Suri CR; Rishi P
Sci Rep; 2019 Dec; 9(1):18404. PubMed ID: 31804525
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune response induced by Salmonella enterica serotype Typhi iron-regulated outer-membrane proteins at peripheral and mucosal levels.
Sood S; Rishi P; Vohra H; Sharma S; Ganguly NK
J Med Microbiol; 2005 Sep; 54(Pt 9):815-821. PubMed ID: 16091431
[TBL] [Abstract][Full Text] [Related]
20. Significance of Vi Negative Isolates of Salmonella Enterica Serovar Typhi.
Haque A
Adv Exp Med Biol; 2018; 1052():9-18. PubMed ID: 29785477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
